We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less capital invested

Capital invested by funds: $900M → $898M (-$2.6M)

1.58% less ownership

Funds ownership: 109.35% → 107.77% (-1.6%)

3% less funds holding

Funds holding: 163 → 158 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

88% less call options, than puts

Call options by funds: $2K | Put options by funds: $16K

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
61
Reduced
43
Closed
20
Calls
$2K
Puts
$16K
Net Calls
-$14K
Net Calls Change
-$1M

Top Buyers

1
Principal Financial Group
Principal Financial Group
Iowa
+$7.48M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.47M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.37M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.96M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$17.5M
2
SAM
Silvercrest Asset Management
New York
-$5.3M
3
BlackRock
BlackRock
New York
-$5.08M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.16M
5
RHJA
Rice Hall James & Associates
California
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
Schroder Investment Management Group
51
Schroder Investment Management Group
United Kingdom
$1.55M +$88.2K +3,819 +6%
AFAS
52
Acorn Financial Advisory Services
Virginia
$1.34M +$22.9K +993 +2%
Two Sigma Advisers
53
Two Sigma Advisers
New York
$1.34M -$665K -28,800 -34%
NC
54
NBW Capital
Massachusetts
$1.33M +$51.4K +2,225 +4%
Barclays
55
Barclays
United Kingdom
$1.19M -$537K -23,229 -32%
GC
56
Guggenheim Capital
Illinois
$1.17M -$44.5K -1,926 -4%
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
$1.16M – – –
CSS
58
Cubist Systematic Strategies
Connecticut
$1.15M -$157K -6,796 -12%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$1.15M -$74.8K -3,238 -6%
RG
60
Renaissance Group
Kentucky
$1.13M +$238K +10,315 +28%
GC
61
Globeflex Capital
California
$1.12M – – –
WG
62
Winton Group
United Kingdom
$1.06M -$43.3K -1,875 -4%
AllianceBernstein
63
AllianceBernstein
Tennessee
$1.06M – – –
Two Sigma Investments
64
Two Sigma Investments
New York
$987K -$17.9K -774 -2%
Prudential Financial
65
Prudential Financial
New Jersey
$930K -$33.5K -1,450 -4%
Bank of America
66
Bank of America
North Carolina
$891K -$430K -18,605 -33%
VFA
67
Values First Advisors
Tennessee
$880K +$99.9K +4,325 +13%
CAM
68
ClariVest Asset Management
California
$844K – – –
VRS
69
Virginia Retirement Systems
Virginia
$799K +$245K +10,600 +46%
MC
70
Maverick Capital
Texas
$798K +$780K +33,751 New
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$763K +$6.79K +294 +0.9%
PAM
72
Panagora Asset Management
Massachusetts
$731K -$144K -6,221 -17%
HAG
73
HighPoint Advisor Group
Illinois
$724K +$2.73K +118 +0.4%
Canada Life
74
Canada Life
Manitoba, Canada
$708K – – –
Squarepoint
75
Squarepoint
New York
$688K +$419K +18,147 +166%
1 2
3
4 5

COLL Hedge Fund Activity: Q2 2021 in Review

158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.

The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.

  • 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
  • Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
  • The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2021.